Showing results (101-110 of 283) with videos related to
Sort By:
Pageof 29
Chemical Biology & Drug Design|April 14, 2006
Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitorsFranco Chimenti, Adriana Bolasco, Fedele Manna, et al.Bioorganic & Medicinal Chemistry Letters|February 24, 2007
Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffoldStefano Alcaro, Anna Artese, James N Iley, et al.Bioorganic & Medicinal Chemistry Letters|November 22, 2002
Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivativesFedele Manna, Franco Chimenti, Adriana Bolasco, et al.Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 25, 2016
SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for InhibitionCristina Talarico, Vincenzo Dattilo, Lucia D'Antona, et al.Journal of Medicinal Chemistry|April 22, 2009
Chalcones: a valid scaffold for monoamine oxidases inhibitorsFranco Chimenti, Rossella Fioravanti, Adriana Bolasco, et al.Bioorganic & Medicinal Chemistry|April 26, 2005
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 propertiesStefano Alcaro, Adriana Arena, Rosaria Di Bella, et al.Bioorganic & Medicinal Chemistry Letters|June 9, 2006
Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of N,N'-bis[2-oxo-2H-benzopyran]-3-carboxamidesFranco Chimenti, Daniela Secci, Adriana Bolasco, et al.Molecules (Basel, Switzerland)|November 13, 2021
Anti-Multiple Myeloma Potential of Secondary Metabolites from Hibiscus sabdariffa-Part 2Alessio Malacrida, Valeria Cavalloro, Emanuela Martino, et al.Journal of Chemical Information and Modeling|June 28, 2024
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational ApproachesLisa Lombardo, Salvatore Mirabile, Rosaria Gitto, et al.Journal of Medicinal Chemistry|May 13, 2005
Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands. development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory propertiesAndrea Cappelli, Andrea Gallelli, Monica Manini, et al.Pageof 29